First mpox vaccine approved by WHO in effort to combat disease in Africa

The World Health Organisation has granted its first authorisation for an mpox vaccine in adults, produced by Bavarian Nordic A/S. This marks a significant step in combating the disease, especially in Africa. The two-dose vaccine is approved for those aged 18 and above, with limited supplies available. WHO aims to ensure fair distribution of vaccines.